IL245045D0 - Selective pyy compounds and uses thereof - Google Patents

Selective pyy compounds and uses thereof

Info

Publication number
IL245045D0
IL245045D0 IL245045A IL24504516A IL245045D0 IL 245045 D0 IL245045 D0 IL 245045D0 IL 245045 A IL245045 A IL 245045A IL 24504516 A IL24504516 A IL 24504516A IL 245045 D0 IL245045 D0 IL 245045D0
Authority
IL
Israel
Prior art keywords
uses
pyy compounds
selective
selective pyy
compounds
Prior art date
Application number
IL245045A
Other languages
Hebrew (he)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP13193082 priority Critical
Priority to US201361906020P priority
Priority to EP14176725 priority
Priority to PCT/EP2014/074476 priority patent/WO2015071355A1/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL245045D0 publication Critical patent/IL245045D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
IL245045A 2013-11-15 2016-04-11 Selective pyy compounds and uses thereof IL245045D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP13193082 2013-11-15
US201361906020P true 2013-11-19 2013-11-19
EP14176725 2014-07-11
PCT/EP2014/074476 WO2015071355A1 (en) 2013-11-15 2014-11-13 Selective pyy compounds and uses thereof

Publications (1)

Publication Number Publication Date
IL245045D0 true IL245045D0 (en) 2016-05-31

Family

ID=53056816

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245045A IL245045D0 (en) 2013-11-15 2016-04-11 Selective pyy compounds and uses thereof

Country Status (13)

Country Link
US (2) US9085637B2 (en)
EP (1) EP3068421B1 (en)
JP (1) JP2017505284A (en)
KR (1) KR20160075819A (en)
CN (1) CN105722526A (en)
AU (1) AU2014350197B2 (en)
BR (1) BR112016010383A2 (en)
CA (1) CA2929672A1 (en)
IL (1) IL245045D0 (en)
MX (1) MX2016006053A (en)
RU (1) RU2678312C1 (en)
TW (1) TW201605467A (en)
WO (1) WO2015071355A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014261111B2 (en) * 2013-05-02 2017-03-16 Glaxosmithkline Intellectual Property Development Limited Therapeutic peptides
US9085637B2 (en) 2013-11-15 2015-07-21 Novo Nordisk A/S Selective PYY compounds and uses thereof
US20160263197A1 (en) * 2013-11-15 2016-09-15 Novon Nordisk A/S HPYY(1-36) Having a Beta-Homoarginine Substitution at Position 35
AR104984A1 (en) * 2015-06-12 2017-08-30 Novo Nordisk As selective compounds and their uses pyy
WO2017186896A1 (en) * 2016-04-28 2017-11-02 Novo Nordisk A/S Semaglutide in cardiovascular conditions
WO2018083335A1 (en) 2016-11-07 2018-05-11 Novo Nordisk A/S Dchbs-active esters of peg compounds and their use
WO2019016300A1 (en) 2017-07-19 2019-01-24 Novo Nordisk A/S Egf(a) analogues, preparation, formulations and uses thereof
WO2019106193A1 (en) 2017-12-01 2019-06-06 University Of Copenhagen Peptide hormone with one or more o-glycans

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685803B2 (en) 1993-03-29 1998-01-29 University Of Cincinnati, The Analogs of peptide YY and uses thereof
US5574010A (en) 1994-11-14 1996-11-12 The Regents Of The University Of California Treatment of pancreatic tumors with peptide YY and analogs thereof
CA2271788A1 (en) 1996-11-13 1998-05-22 University Of Cincinnati Analogs of peptide yy and uses thereof
EP0908515A3 (en) 1997-09-16 2000-04-26 Smithkline Beecham Plc Pancreatic polypeptide
US6046167A (en) 1998-03-25 2000-04-04 University Of Cincinnati Peptide YY analogs
IL139913D0 (en) 1998-06-08 2002-02-10 Schering Corp Neuropeptide y5 receptor antagonists
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
WO2002047712A2 (en) 2000-12-14 2002-06-20 Amylin Pharmaceuticals, Inc. Peptide yy and peptide yy agonists for treatment of metabolic disorders
US6589938B2 (en) 2001-06-29 2003-07-08 National University Of Singapore Use of angiotensin I derivatives as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders
US7459432B2 (en) 2001-09-24 2008-12-02 Imperial College Innovations Ltd. Modification of feeding behavior
US8058233B2 (en) 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
EP2277527A3 (en) 2003-01-17 2011-08-31 Ipsen Pharma Peptide YY analogs
US7572581B2 (en) 2003-06-30 2009-08-11 Roche Molecular Systems, Inc. 2′-terminator nucleotide-related methods and systems
EP1667724A2 (en) 2003-09-19 2006-06-14 Novo Nordisk A/S Albumin-binding derivatives of therapeutic peptides
MXPA06002941A (en) 2003-09-19 2006-05-31 Novo Nordisk As Albumin-binding derivatives of therapeutic peptides.
CN101380476A (en) 2003-09-19 2009-03-11 诺沃挪第克公司 Albumin-binding derivatives of therapeutic peptides
CA2550050A1 (en) 2003-12-18 2005-06-30 Novo Nordisk A/S Novel glp-1 analogues linked to albumin-like agents
EP2335716A3 (en) 2004-02-11 2011-10-19 Amylin Pharmaceuticals Inc. Pancreatic polypeptide family motifs and polypeptides comprising the same
EP2417980A1 (en) 2004-02-11 2012-02-15 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties
CN101361967A (en) 2004-03-17 2009-02-11 7Tm制药联合股份有限公司 Y2/Y4 selective receptor agonists for therapeutic interventions
EA012071B1 (en) 2004-03-17 2009-08-28 7ТиЭм ФАРМА А/С Y4 selective receptor agonists for therapeutic intervention
AU2005224026A1 (en) 2004-03-17 2005-09-29 7Tm Pharma A/S Y2 selective receptor agonists for therapeutic interventions
EA011861B1 (en) 2004-03-17 2009-06-30 7ТиЭм ФАРМА А/С Y2/y4 selective receptor agonists for therapeutic interventions
GB0412181D0 (en) 2004-06-01 2004-06-30 Celltech R&D Ltd Biological products
WO2006005667A2 (en) 2004-07-08 2006-01-19 Novo Nordisk A/S Polypeptide protracting tags comprising a tetrazole moiety
WO2006020207A2 (en) 2004-07-19 2006-02-23 University Of Cincinnati Compounds for control of appetite
WO2006049681A2 (en) 2004-08-30 2006-05-11 Bayer Pharmaceuticals Corporation Selective neuropeptide y2 receptor agonists
US7410949B2 (en) 2005-01-18 2008-08-12 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
GB0504857D0 (en) 2005-03-09 2005-04-13 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
WO2007008778A2 (en) 2005-07-11 2007-01-18 Nastech Pharmaceutical Company Inc. Formulations for enhanced mucosal delivery of pyy
CA2616583A1 (en) 2005-07-18 2007-01-25 Novo-Nordisk A/S Peptides for use in the treatment of obesity
CA2623088A1 (en) 2005-09-21 2007-04-12 7Tm Pharma A/S Y4 selective receptor agonists for therapeutic interventions
EP1934245B1 (en) 2005-09-21 2011-07-13 7TM Pharma A/S Y2 selective receptor agonists for therapeutic interventions
JP5000663B2 (en) 2005-12-07 2012-08-15 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Neuropeptide-2 receptor agonist
EP1963343A1 (en) 2005-12-14 2008-09-03 Novo Nordisk A/S Polypeptide protracting tags
US20070197445A1 (en) 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
US20090186817A1 (en) 2006-03-21 2009-07-23 Amylin Pharmaceuticals, Inc. Peptide-peptidase inhibitor conjugates and methods of using same
GB0613196D0 (en) 2006-07-03 2006-08-09 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
GB0621973D0 (en) 2006-11-03 2006-12-13 Philogen Spa Binding molecules and uses thereof
US20090099074A1 (en) 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
WO2008087190A2 (en) 2007-01-18 2008-07-24 Novo Nordisk A/S Use of peptides in combination with surgical intervention for the treatment of obesity
US20100016237A1 (en) 2007-01-18 2010-01-21 Novo Nordisk A/S Novel Peptides for Use in the Treatment of Obesity
GB0708226D0 (en) 2007-04-27 2007-06-06 7Tm Pharma As Y-receptor agonists
EP2322620A3 (en) 2007-07-09 2011-08-31 Imperial Innovations Ltd. Analogs of human pancreatic polypeptide and their effects on feeding behaviour
EP2190460B1 (en) 2007-09-05 2014-12-17 Novo Nordisk A/S Peptides derivatized with a-b-c-d- and their therapeutical use
EP2187949A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of glp-1 as a therapeutic agent
WO2009042922A2 (en) 2007-09-27 2009-04-02 Amylin Pharmaceuticals, Inc. Peptide-peptidase inhibitor conjugates and methods of making and using same
AU2009248041B2 (en) 2008-05-16 2013-10-03 Novo Nordisk A/S Long-acting Y2 and/or Y4 receptor agonists
US8299023B2 (en) * 2008-09-17 2012-10-30 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists
GB0817067D0 (en) 2008-09-18 2008-10-22 7Tm Pharma As Intestinal treatment
BRPI0921230A2 (en) * 2008-11-05 2018-10-30 Hoffmann La Roche neuropeptide-2 receptor agonists (y-2r) and uses of same.
JP5584236B2 (en) 2009-02-20 2014-09-03 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエIpsen Pharma S.A.S. Cytotoxic conjugate having neuropeptide y receptor binding compounds
CN102573888A (en) * 2009-09-18 2012-07-11 诺和诺德公司 Long-acting Y2 receptor agonists
EP2488195A2 (en) 2009-10-13 2012-08-22 F.Hoffmann-La Roche Ag Neuropeptide-2 receptor (y-2r) agonists
CN102905722A (en) * 2009-11-13 2013-01-30 诺沃—诺迪斯克有限公司 Long-acting Y2 receptor agonists
WO2011131646A1 (en) 2010-04-20 2011-10-27 Novo Nordisk A/S Long-acting gastrin derivatives
EA201201508A1 (en) * 2010-05-05 2013-05-30 Бёрингер Ингельхайм Интернациональ Гмбх combination therapy
GB201101459D0 (en) 2011-01-27 2011-03-16 Imp Innovations Ltd Novel compounds and thier effects on fedding behaviour
EP2855517A1 (en) 2012-05-29 2015-04-08 Novo Nordisk A/S Pancreatic polypeptide compounds and use
AU2014261111B2 (en) * 2013-05-02 2017-03-16 Glaxosmithkline Intellectual Property Development Limited Therapeutic peptides
US9085637B2 (en) * 2013-11-15 2015-07-21 Novo Nordisk A/S Selective PYY compounds and uses thereof
US20160263197A1 (en) 2013-11-15 2016-09-15 Novon Nordisk A/S HPYY(1-36) Having a Beta-Homoarginine Substitution at Position 35
AR104984A1 (en) * 2015-06-12 2017-08-30 Novo Nordisk As selective compounds and their uses pyy

Also Published As

Publication number Publication date
AU2014350197B2 (en) 2018-10-04
EP3068421B1 (en) 2019-04-17
KR20160075819A (en) 2016-06-29
US20160289283A1 (en) 2016-10-06
TW201605467A (en) 2016-02-16
AU2014350197A1 (en) 2016-05-05
US9085637B2 (en) 2015-07-21
WO2015071355A1 (en) 2015-05-21
CN105722526A (en) 2016-06-29
RU2016119121A (en) 2017-12-20
RU2678312C1 (en) 2019-01-25
MX2016006053A (en) 2016-08-17
EP3068421A1 (en) 2016-09-21
CA2929672A1 (en) 2015-05-21
US10246497B2 (en) 2019-04-02
BR112016010383A2 (en) 2017-12-05
JP2017505284A (en) 2017-02-16
US20150152150A1 (en) 2015-06-04

Similar Documents

Publication Publication Date Title
GB201311001D0 (en) Lucabella
PL2953956T3 (en) Heteropolyoxometalates
TWI507647B (en) Air-exchanging device
IL240275D0 (en) Selective antisense compounds and uses thereof
IL244432D0 (en) Aza-pyridone compounds and uses thereof
EP2973543A4 (en) Providing content on multiple devices
EP2958895A4 (en) Therapeutic compounds and uses thereof
EP2989885A4 (en) Combine
HK1219663A1 (en) Drug combinations
IL244214A (en) Thienopiperidine derivative and use thereof
GB201317286D0 (en) Composition and Use
GB2514689B (en) Quick-Coupler
EP2957205A4 (en) Hand-dryer
EP3000028A4 (en) Auto-calendaring
IL245045D0 (en) Selective pyy compounds and uses thereof
DK3030549T3 (en) Pyridazinon compounds and uses thereof
HK1217092A1 (en) Therapeutic compounds and uses thereof
ZA201505682B (en) Microanchor
RS57838B1 (en) Arylquinazolines
LT2968313T (en) Drug combination
GB2526466B (en) Blend
RS56689B1 (en) Footlet
GB201323008D0 (en) Compounds and uses thereof
TWI565762B (en) Hardmask
GB2511570B (en) Hand-warmer